Wells Fargo & Company Revolution Medicines, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 55,273 shares of RVMD stock, worth $3.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

55,273

Previous 43,802 26.19%

Holding current value

$3.09 Million

Previous $1.41 Million 52.02%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$30.14 - $40.68 $345,735 - $466,640	11,471 Added 26.19%	55,273 $2.15 Million
Q1 2024 May 10, 2024	BUY	$26.56 - $33.55 $101,884 - $128,697	3,836 Added 9.6%	43,802 $1.41 Million
Q4 2023 Feb 09, 2024	SELL	$18.35 - $34.12 $416,141 - $773,773	-22,678 Reduced 36.2%	39,966 $1.15 Million
Q3 2023 Nov 13, 2023	SELL	$25.17 - $35.05 $906,648 - $1.26 Million	-36,021 Reduced 36.51%	62,644 $1.73 Million
Q2 2023 Aug 15, 2023	BUY	$20.28 - $27.0 $552,609 - $735,723	27,249 Added 38.16%	98,665 $2.64 Million
Q1 2023 May 12, 2023	BUY	$20.76 - $30.09 $1.45 Million - $2.09 Million	69,610 Added 3854.37%	71,416 $1.55 Million
Q4 2022 Feb 13, 2023	SELL	$17.68 - $25.53 $32,106 - $46,362	-1,816 Reduced 50.14%	1,806 $43,000
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $6,687 - $9,958	383 Added 11.82%	3,622 $71,000
Q2 2022 Aug 12, 2022	SELL	$14.54 - $27.17 $320,316 - $598,555	-22,030 Reduced 87.18%	3,239 $63,000
Q1 2022 May 16, 2022	SELL	$17.31 - $26.4 $362,661 - $553,106	-20,951 Reduced 45.33%	25,269 $646,000
Q4 2021 Feb 14, 2022	SELL	$24.35 - $33.7 $307,150 - $425,091	-12,614 Reduced 21.44%	46,220 $1.16 Million
Q3 2021 Nov 15, 2021	BUY	$23.95 - $33.41 $1 Million - $1.4 Million	41,915 Added 247.74%	58,834 $1.62 Million
Q2 2021 Aug 16, 2021	BUY	$29.0 - $47.44 $135,691 - $221,971	4,679 Added 38.23%	16,919 $536,000
Q1 2021 May 13, 2021	SELL	$37.21 - $54.43 $2.61 Million - $3.81 Million	-70,054 Reduced 85.13%	12,240 $561,000
Q4 2020 Feb 09, 2021	BUY	$30.19 - $45.49 $1.08 Million - $1.62 Million	35,617 Added 76.31%	82,294 $3.26 Million
Q3 2020 Nov 05, 2020	BUY	$22.61 - $34.8 $153,770 - $236,674	6,801 Added 17.06%	46,677 $1.62 Million
Q2 2020 Aug 13, 2020	BUY	$19.65 - $39.34 $617,854 - $1.24 Million	31,443 Added 372.86%	39,876 $1.26 Million
Q1 2020 May 14, 2020	BUY	$20.0 - $34.08 $168,660 - $287,396	8,433 New	8,433 $185,000

Others Institutions Holding RVMD

# of Institutions

242

Shares Held

161M

Call Options Held

251K

Put Options Held

133K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $4.9B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Revolution Medicines, Inc. Transaction History